<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.2?>
<?ConverterInfo.XSLTName jats2jats3.xsl?>
<?ConverterInfo.Version 1?>
<?properties open_access?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Bioinformatics</journal-id>
    <journal-id journal-id-type="iso-abbrev">Bioinformatics</journal-id>
    <journal-id journal-id-type="publisher-id">bioinformatics</journal-id>
    <journal-title-group>
      <journal-title>Bioinformatics</journal-title>
    </journal-title-group>
    <issn pub-type="ppub">1367-4803</issn>
    <issn pub-type="epub">1367-4811</issn>
    <publisher>
      <publisher-name>Oxford University Press</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">8352501</article-id>
    <article-id pub-id-type="pmid">33196775</article-id>
    <article-id pub-id-type="doi">10.1093/bioinformatics/btaa967</article-id>
    <article-id pub-id-type="publisher-id">btaa967</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Applications Notes</subject>
        <subj-group subj-group-type="category-toc-heading">
          <subject>Systems Biology</subject>
        </subj-group>
      </subj-group>
      <subj-group subj-group-type="category-taxonomy-collection">
        <subject>AcademicSubjects/SCI01060</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Metabolite-Investigator: an integrated user-friendly workflow for metabolomics multi-study analysis</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Beuchel</surname>
          <given-names>Carl</given-names>
        </name>
        <aff><institution>Institute for Medical Informatics, Statistics and Epidemiology, Leipzig University</institution>, 04107 Leipzig, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3126-7950</contrib-id>
        <name>
          <surname>Kirsten</surname>
          <given-names>Holger</given-names>
        </name>
        <aff><institution>Institute for Medical Informatics, Statistics and Epidemiology, Leipzig University</institution>, 04107 Leipzig, <country country="DE">Germany</country></aff>
        <aff><institution>LIFE – Leipzig Research Center for Civilization Diseases</institution>, 04103 Leipzig, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ceglarek</surname>
          <given-names>Uta</given-names>
        </name>
        <aff><institution>Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, Leipzig University</institution>, 04103 Leipzig, <country country="DE">Germany</country></aff>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Scholz</surname>
          <given-names>Markus</given-names>
        </name>
        <xref rid="btaa967-cor1" ref-type="corresp"/>
        <aff><institution>Institute for Medical Informatics, Statistics and Epidemiology, Leipzig University</institution>, 04107 Leipzig, <country country="DE">Germany</country></aff>
        <aff><institution>LIFE – Leipzig Research Center for Civilization Diseases</institution>, 04103 Leipzig, <country country="DE">Germany</country></aff>
        <aff><institution>IFB AdiposityDiseases, University Hospital Leipzig</institution>, 04103 Leipzig, <country country="DE">Germany</country></aff>
        <!--markus.scholz@imise.uni-leipzig.de-->
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Pier Luigi</surname>
          <given-names>Martelli</given-names>
        </name>
        <role>Associate Editor</role>
      </contrib>
    </contrib-group>
    <author-notes>
      <corresp id="btaa967-cor1">To whom correspondence should be addressed. <email>markus.scholz@imise.uni-leipzig.de</email></corresp>
    </author-notes>
    <pub-date pub-type="collection">
      <day>01</day>
      <month>8</month>
      <year>2021</year>
    </pub-date>
    <pub-date pub-type="epub" iso-8601-date="2020-11-16">
      <day>16</day>
      <month>11</month>
      <year>2020</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>16</day>
      <month>11</month>
      <year>2020</year>
    </pub-date>
    <volume>37</volume>
    <issue>15</issue>
    <fpage>2218</fpage>
    <lpage>2220</lpage>
    <history>
      <date date-type="received">
        <day>16</day>
        <month>6</month>
        <year>2020</year>
      </date>
      <date date-type="rev-recd">
        <day>13</day>
        <month>10</month>
        <year>2020</year>
      </date>
      <date date-type="editorial-decision">
        <day>01</day>
        <month>11</month>
        <year>2020</year>
      </date>
      <date date-type="accepted">
        <day>04</day>
        <month>11</month>
        <year>2020</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2020. Published by Oxford University Press.</copyright-statement>
      <copyright-year>2020</copyright-year>
      <license>
        <ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbynclicense">https://creativecommons.org/licenses/by-nc/4.0/</ali:license_ref>
        <license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc/4.0/">http://creativecommons.org/licenses/by-nc/4.0/</ext-link>), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="btaa967.pdf"/>
    <abstract>
      <title>Abstract</title>
      <sec id="s1">
        <title>Motivation</title>
        <p>Many diseases have a metabolic background, which is increasingly investigated due to improved measurement techniques allowing high-throughput assessment of metabolic features in several body fluids. Integrating data from multiple cohorts is of high importance to obtain robust and reproducible results. However, considerable variability across studies due to differences in sampling, measurement techniques and study populations needs to be accounted for.</p>
      </sec>
      <sec id="s2">
        <title>Results</title>
        <p>We present <italic toggle="yes">Metabolite-Investigator</italic>, a scalable analysis workflow for quantitative metabolomics data from multiple studies. Our tool supports all aspects of data pre-processing including data integration, cleaning, transformation, batch analysis as well as multiple analysis methods including uni- and multivariable factor-metabolite associations, network analysis and factor prioritization in one or more cohorts. Moreover, it allows identifying critical interactions between cohorts and factors affecting metabolite levels and inferring a common covariate model, all via a graphical user interface.</p>
      </sec>
      <sec id="s3">
        <title>Availability and implementation</title>
        <p>We constructed <italic toggle="yes">Metabolite-Investigator</italic> as a free and open web-tool and stand-alone Shiny-app. It is hosted at <ext-link xlink:href="https://apps.health-atlas.de/metabolite-investigator/" ext-link-type="uri">https://apps.health-atlas.de/metabolite-investigator/</ext-link>, the source code is freely available at <ext-link xlink:href="https://github.com/cfbeuchel/Metabolite-Investigator" ext-link-type="uri">https://github.com/cfbeuchel/Metabolite-Investigator</ext-link>.</p>
      </sec>
      <sec id="s5">
        <title>Supplementary information</title>
        <p><xref rid="sup1" ref-type="supplementary-material">Supplementary data</xref> are available at <italic toggle="yes">Bioinformatics</italic> online.</p>
      </sec>
    </abstract>
    <abstract abstract-type="graphical">
      <title>Graphical Abstract</title>
      <p>
        <fig position="float" id="btaa967-F2">
          <graphic xlink:href="btaa967f2" position="float"/>
        </fig>
      </p>
    </abstract>
    <funding-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Federal Ministry of Education and Research</institution>
            <institution-id institution-id-type="DOI">10.13039/501100002347</institution-id>
          </institution-wrap>
        </funding-source>
        <award-id>01EO1501.AD2-7117</award-id>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>Leipzig Research Center for Civilization Diseases</institution>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>European Union</institution>
            <institution-id institution-id-type="DOI">10.13039/501100000780</institution-id>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>European Regional Development Fund</institution>
            <institution-id institution-id-type="DOI">10.13039/501100008530</institution-id>
          </institution-wrap>
        </funding-source>
      </award-group>
      <award-group award-type="grant">
        <funding-source>
          <institution-wrap>
            <institution>German Ministry of Education and Research</institution>
          </institution-wrap>
        </funding-source>
        <award-id>031L0026</award-id>
      </award-group>
    </funding-group>
    <counts>
      <page-count count="3"/>
    </counts>
  </article-meta>
</front>
<body>
  <sec>
    <title>1 Introduction</title>
    <p>Many diseases have a metabolic background, which is increasingly recognized in basic and medical research (<xref rid="btaa967-B10" ref-type="bibr">Liu <italic toggle="yes">et al.</italic>, 2019</xref>). Accordingly, metabolomics measurements were commenced in large cohorts to unravel disease mechanisms and to develop effective treatment concepts (<xref rid="btaa967-B1" ref-type="bibr">Abbiss <italic toggle="yes">et al.</italic>, 2019</xref>; <xref rid="btaa967-B7" ref-type="bibr">Iida <italic toggle="yes">et al.</italic>, 2019</xref>; <xref rid="btaa967-B12" ref-type="bibr">Souza <italic toggle="yes">et al.</italic>, 2019</xref>). Specifically, metabolomics by mass-spectrometry allows analysis of defined metabolomics features in high-throughput and with high sensitivity in several body fluids and cellular compartments (<xref rid="btaa967-B4" ref-type="bibr">Cambiaghi <italic toggle="yes">et al.</italic>, 2017</xref>).</p>
    <p>We here propose a general analysis framework to analyse large-scale metabolic data of several studies in parallel, considering typical data analysis issues of LC-MS-based metabolomics data. Particularly, the tool allows for (i) Metabolite pre-processing accounting for outliers, zero-inflation (an excess of zero values in the data, resulting in skewed distributions) and technical batch-effects, (ii) Identification of uni- and multivariable effects of individual factors influencing the metabolome and analysis of heterogeneity of these effects across studies, (iii) Selection and prioritization of factors as covariates for metabolite analyses. With these features, our tool is particularly well suited to verify, e.g. the effect of factors on metabolites across independent studies.</p>
    <p>We optimized these methods and analysis steps on the basis of a large simulation study to propose a general workflow applicable to many situations, combining streamlined pre-processing with a comprehensive multi-study analysis not yet available in other applications. The workflow was implemented as an interactive Shiny-application (<xref rid="btaa967-B5" ref-type="bibr">Winston Chang <italic toggle="yes">et al.</italic>, 2019</xref>) called <italic toggle="yes">Metabolite-Investigator</italic>, providing an intuitive graphical-user-interface. We here present the implemented methods, workflow and an example application based on a real-world example.</p>
  </sec>
  <sec>
    <title>2 Implemented methods and workflow</title>
    <p>The general analysis workflow of <italic toggle="yes">Metabolite-Investigator</italic> is depicted in <xref rid="btaa967-F1" ref-type="fig">Figure 1</xref> and a detailed description of the methods, as well as a step-by-step presentation of the workflow can be found in <xref rid="sup1" ref-type="supplementary-material">Supplementary Methods</xref>. Part of the workflow was also applied previously in a study with real data (<xref rid="btaa967-B3" ref-type="bibr">Beuchel <italic toggle="yes">et al.</italic>, 2019</xref>). Briefly, the tool starts with tabular, raw quantitative metabolome data, also allowing upload of data using standardized file formats mwTab and mzTab-m 2 and performs data integration and further pre-processing considering a number of typical issues of these kind of data (<xref rid="btaa967-B6" ref-type="bibr">Hoffmann <italic toggle="yes">et al.</italic>, 2019</xref>). The primary function of the tool is to identify and visualize relationships between individual factors such as age, sex or laboratory parameters like blood cell counts with metabolomics features and to select a suitable covariate model for joint regression analysis of data from one or multiple cohorts.</p>
    <fig position="float" id="btaa967-F1">
      <label>Fig. 1.</label>
      <caption>
        <p>Schematic workflow of the tool <italic toggle="yes">Metabolite-Investigator</italic>. The application identifies and characterizes relationships between influencing factors and metabolomics features in single or multiple studies. The workflow is structured as follows: (<bold>A</bold>) available metabolite (<italic toggle="yes">M</italic><sub>1</sub>, <italic toggle="yes">M</italic><sub>2</sub>, …, <italic toggle="yes">M<sub>n</sub></italic>) and factor data (<italic toggle="yes">C</italic><sub>1</sub>, <italic toggle="yes">C</italic><sub>2</sub>, …, <italic toggle="yes">C<sub>m</sub></italic>) of all cohorts are loaded into the application and merged. (<bold>B</bold>) Data are pre-processed by filtering outlier measurements, inverse-normal-transformation and batch-adjustment according to the requirements of the user. (<bold>C</bold>) Pearson’s correlations of factors are computed and visualized. Highly correlating factors (marked with a red box and exclamation mark) can be excluded from the multivariable association step to avoid multi-collinearity issues. (<bold>D</bold>) Factor-metabolite relationships are analysed in uni- and multivariable association steps separately in each study. (<bold>E</bold>) Visualizations of the strength of identified relationship between factors and metabolites as interactive bi-partite network. (<bold>F</bold>) Analysis and visualization of effect heterogeneity across multiple studies based on testing for uni- and multivariable interaction effects of the factors with the study identifier. (<bold>G</bold>) Factors are prioritized to assist in the identification of a confounding model applicable to all cohorts for follow up analyses. This is done via backward-selection of factors that explain a user-specified minimum amount of variance in all cohorts. Visualizations and results are available for download</p>
      </caption>
      <graphic xlink:href="btaa967f1" position="float"/>
    </fig>
    <p>The users can follow a structured workflow comprising seven steps shown in <xref rid="btaa967-F1" ref-type="fig">Figure 1</xref> and explained in detail in <xref rid="sup1" ref-type="supplementary-material">Supplementary Methods</xref>. Results are available for download after each step. Thereby, single measurements larger than 5*SD of log-transformed values can be removed as outliers. Possibly skewed data are optionally mitigated by inverse-normal transformation (<xref rid="btaa967-B2" ref-type="bibr">Beasley <italic toggle="yes">et al.</italic>, 2009</xref>). Known technical batch-effects can be addressed by an empirical Bayes method (<xref rid="btaa967-B9" ref-type="bibr">Leek <italic toggle="yes">et al.</italic>, 2012</xref>; <xref rid="btaa967-B8" ref-type="bibr">Johnson <italic toggle="yes">et al.</italic>, 2007</xref>). Univariable linear regression models are fit for each study with metabolites treated as responses and factors as possible predictors. Highly correlating factors are identified and can be removed from further analysis. Remaining factors are fit as joint predictors in multivariable linear regression models of the metabolites. Visualizations of the distribution of effect sizes of factors on metabolites per study as well as factor correlations are presented. The heterogeneity of factor effects on metabolite levels across cohorts is assessed by fitting a factor-by-cohort interaction term in addition to the main effects in the pooled dataset.</p>
    <p>Backward-selection of factors is implemented by fitting all remaining factors as predictors in multivariable regression models of metabolites and removing factors with small explained variance. This procedure is repeated iteratively until a subset of factors is obtained meeting the user-specified threshold of explained variance for at least one of the metabolites in at least one of the studies (see <xref rid="sup1" ref-type="supplementary-material">Supplementary Methods</xref> for details). For the user’s convenience, a pre-formulated methods description is available after analyses.</p>
  </sec>
  <sec>
    <title>3 Case study</title>
    <p>For illustration purposes, we analyse a public dataset of 66 acyl-carnitines quantified using LC-MS/MS and ten experimental factors collected from 366 samples after six weeks of atenolol treatment, that is freely available at <ext-link xlink:href="http://dx.doi.org/10.21228/M8PC7J" ext-link-type="uri">http://dx.doi.org/10.21228/M8PC7J</ext-link>. Our tool allows for quick parsing of the corresponding mwTab format and recognition of analysis-ready columns. After pre-processing and feature annotation, high zero-inflation of all but two metabolites (Acetylcarnitine and Malonylcarnitine) was detected. The backward selection of factors influencing metabolites resulted in a model of three factors, namely race (for Malonylcarnitine), age and baseline glucose (for Acetylcarnitine) (see <xref rid="sup1" ref-type="supplementary-material">Supplementary Methods</xref> for a more detailed description).(Metabolomics Workbench, 2016)</p>
  </sec>
  <sec>
    <title>4 Performance</title>
    <p><italic toggle="yes">Metabolite-Investigator</italic> is scalable to thousands of samples and hundreds of variables. A public dataset (<italic toggle="yes">N</italic> = 366, 66 metabolites, 10 factors) was analysed in under 1 min. Completing all analysis steps for a larger test dataset of 63 metabolites and 10 factors with <italic toggle="yes">N</italic> = 15 260 ran for 12 min using all standard settings on our test machine (16 GB RAM, 3.4 GHz CPU).</p>
  </sec>
  <sec>
    <title>5 Comparison with existing tools</title>
    <p>We compared our tool with other graphical user interface-based tools intended for pre-processing and analysis of metabolite data. Results are presented in <xref rid="sup1" ref-type="supplementary-material">Supplementary Table S1</xref>. Our tool addresses a number of issues not considered in available tools. These comprise appropriate dealing with typical LC-MS/MS data issues including skewness of data and zero-inflation, technical batches, identification of external sources of variation thereby accounting for correlation, scalable identification and prioritization of factors affecting the metabolome (especially when integrating data from multiple studies), and finally, visualization of results, including interactive network analysis.</p>
  </sec>
  <sec>
    <title>6 Conclusion</title>
    <p><italic toggle="yes">Metabolite-Investigator</italic> is an easy-to-use application, offering a standardized workflow for analysis and prioritization of factors affecting metabolite data. Local deployment and availability on a web server allow for online and offline use with no programming skills required. It offers a convenient way for (multi-)study pre-processing and subsequent graphical and table-based exploration of results including study heterogeneity and multivariate effect size based model selection currently not available elsewhere.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Material</title>
    <supplementary-material id="sup1" position="float" content-type="local-data">
      <label>btaa967_Supplementary_Data</label>
      <media xlink:href="btaa967_supplementary_data.docx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <ack id="ack1">
    <title> </title>
    <sec>
      <title>Funding</title>
      <p>M.S. received funding from the Federal Ministry of Education and Research, Germany, FKZ: 01EO1501.AD2-7117. H.K. was supported by the Leipzig Research Center for Civilization Diseases (LIFE). LIFE is funded by means of the European Union, by the European Regional Development Fund (ERDF) and by funds of the Free State of Saxony within the framework of the excellence initiative. The Leipzig Health Atlas is funded by the German Ministry of Education and Research (reference number: 031L0026, program: i: DSem – Integrative Datensemantik in der Systemmedizin).</p>
      <p><italic toggle="yes">Conflict of Interest</italic>: none declared.</p>
    </sec>
  </ack>
  <ref-list id="ref1">
    <title>References</title>
    <ref id="btaa967-B1">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Abbiss</surname><given-names>H.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) 
<article-title>Metabolomics approaches for the diagnosis and understanding of kidney diseases</article-title>. <source>Metabolites</source>, <volume>9</volume>, <fpage>34</fpage>.<pub-id pub-id-type="pmid">30769897</pub-id></mixed-citation>
    </ref>
    <ref id="btaa967-B2">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Beasley</surname><given-names>T.M.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2009</year>) 
<article-title>Rank-based inverse normal transformations are increasingly used, but are they merited?</article-title>  <source>Behav. Genet</source>., <volume>39</volume>, <fpage>580</fpage>–<lpage>595</lpage>.<pub-id pub-id-type="pmid">19526352</pub-id></mixed-citation>
    </ref>
    <ref id="btaa967-B3">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Beuchel</surname><given-names>C.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) 
<article-title>Clinical and lifestyle related factors influencing whole blood metabolite levels – a comparative analysis of three large cohorts</article-title>. <source>Mol. Metab</source>., <volume>29</volume>, <fpage>76</fpage>–<lpage>85</lpage>.<pub-id pub-id-type="pmid">31668394</pub-id></mixed-citation>
    </ref>
    <ref id="btaa967-B4">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cambiaghi</surname><given-names>A.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2017</year>) 
<article-title>Analysis of metabolomic data: tools, current strategies and future challenges for omics data integration</article-title>. <source>Brief. Bioinf</source>., <volume>18</volume>, <fpage>498</fpage>–<lpage>510</lpage>.</mixed-citation>
    </ref>
    <ref id="btaa967-B5">
      <mixed-citation publication-type="other"><person-group person-group-type="author"><string-name><surname>Chang</surname><given-names>W.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) shiny: Web Application Framework for R. <ext-link xlink:href="https://CRAN.R-project.org/package=shiny" ext-link-type="uri">https://CRAN.R-project.org/package=shiny</ext-link>.</mixed-citation>
    </ref>
    <ref id="btaa967-B6">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Hoffmann</surname><given-names>N.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) 
<article-title>mzTab-M: a data standard for sharing quantitative results in mass spectrometry metabolomics</article-title>. <source>Anal. Chem</source>., <volume>91</volume>, <fpage>3302</fpage>–<lpage>3310</lpage>.<pub-id pub-id-type="pmid">30688441</pub-id></mixed-citation>
    </ref>
    <ref id="btaa967-B7">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Iida</surname><given-names>M.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) 
<article-title>Application of metabolomics to epidemiological studies of atherosclerosis and cardiovascular disease</article-title>. <source>J. Atheroscl. Thromb</source>., <volume>26</volume>, <fpage>747</fpage>–<lpage>757</lpage>.</mixed-citation>
    </ref>
    <ref id="btaa967-B8">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Johnson</surname><given-names>W.E.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2007</year>) 
<article-title>Adjusting batch effects in microarray expression data using empirical Bayes methods</article-title>. <source>Biostatistics (Oxford, England)</source>, <volume>8</volume>, <fpage>118</fpage>–<lpage>127</lpage>.<pub-id pub-id-type="pmid">16632515</pub-id></mixed-citation>
    </ref>
    <ref id="btaa967-B9">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Leek</surname><given-names>J.T.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2012</year>) 
<article-title>The SVA package for removing batch effects and other unwanted variation in high-throughput experiments</article-title>. <source>Bioinformatics (Oxford, England)</source>, <volume>28</volume>, <fpage>882</fpage>–<lpage>883</lpage>.<pub-id pub-id-type="pmid">22257669</pub-id></mixed-citation>
    </ref>
    <ref id="btaa967-B10">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Liu</surname><given-names>X.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) 
<article-title>New advances in analytical methods for mass spectrometry-based large-scale metabolomics study</article-title>. <source>TrAC Trends Anal. Chem</source>., <volume>121</volume>, <fpage>115665</fpage>.</mixed-citation>
    </ref>
    <ref id="btaa967-B12">
      <mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Souza</surname><given-names>R.T.</given-names></string-name></person-group>  <etal>et al</etal> (<year>2019</year>) 
<article-title>Use of metabolomics for predicting spontaneous preterm birth in asymptomatic pregnant women: protocol for a systematic review and meta-analysis</article-title>. <source>BMJ Open</source>, <volume>9</volume>, <fpage>e026033</fpage>.</mixed-citation>
    </ref>
  </ref-list>
</back>
